SEROLOGICAL ACTIVITY OF VACCINE AND CIRCULATING BORDETELLA PERTUSSIS STRAINS


Cite item

Full Text

Abstract

Aim. To study activity of vaccine and circulating strains of Bordetella pertussis in serological reactions with serum samples from healthy vaccinated children and children with pertussis infection. Materials and methods. One hundred forty-six serum samples from children with pertussis infection as well as 158 samples from healthy vaccinated children aged 3—5 years old were studied. Serologic activity of 3 vaccine strains and 7 strains of B.pertussis isolated from patients with pertussis in 2001—2005 against sera of children with pertussis infection or vaccinated children was assessed with hemagglutination assay (HA), radial gel immunodiffusion (RGI), and immunoelectro- phoresis (IEP). Results. In HA both serum samples of infected and vaccinated children were equally active in agglutination of microbial preparations prepared from vaccine or recently isolated strains of B.pertussis. RGI assay showed that 81 — 84% of serum samples from infected children and 17-19% of samples from healthy vaccinated children reacted with vaccine strains, and 81-85% of samples from infected children and 16-20% of samples from healthy vaccinated children reacted with circulating strains. Sera from patients with pertussis formed identical lines of precipitation with vaccine and circulating strains in RGI assay and three types of precipitation arches profile in IEP. Sera from healthy vaccinated children formed identical precipitation arches with vaccine and circulating strains in RGI assay and one type of precipitation arches profile in IEP. Conclusion. Antibodies of patients with pertussis were equally active against vaccine and circulating strains of B. pertussis. Antibodies of vaccinated children were also equally active against vaccine and circulating strains although revealed more narrow spectrum of antigens compared to children with pertussis infection.

Full Text

СЕРОЛОГИЧЕСКАЯ АКТИВНОСТЬ ВАКЦИННЫХ И ЦИРКУЛИРУЮЩИХ ШТАММОВ BORDETELLA PERTUSSIS
×

About the authors

E. M Zaitsev

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

L. I Krasnoproshina

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

N. U Mertsalova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

I. K Mazurova

Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russia

N. S Zakharova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

References

  1. Семина Н.А., Селезнева Т.С., Заргарьянц А.И. Эпидемиологический надзор за коклюшной инфекцией. Метод. ук. МУ 3.1.2.2160-07. М., Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2007.
  2. Шинкарев А.С., Мерцалова Н.У., Мазурова И.К. и др. Современные штаммы Bordetella рertussis: иммунобиологические свойства и совершенствование вакцины. Журн. микробиол. 2007, 4: 20-25.
  3. Kallonen T., He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert. Rev. Vac. 2009, 8(7): 863-875.
  4. Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. Evol. 2010, 10(1): 36-49.
  5. Pereira A., Pietro Pereira A.S. et al. Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis. Am.J.Trop.Med. Hyg. 2010, 82(4): 678-682.
  6. He Q, Mertsola J. Factors contributing to pertussis resurgence. Fut. Microbiol. 2008, 3: 329-339.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Zaitsev E.M., Krasnoproshina L.I., Mertsalova N.U., Mazurova I.K., Zakharova N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies